|
|
|
|
|
|
| COVID-19 |
 |
|
Risks to Pharma Commercialization |
Identifying and acting on the risks developing in the major markets in light of COVID-19 disruption and the implications for assets in late-stage clinical development and early commercialization
… /Read more/ |
|
|
| COVID-19 |
| Advertisement |
Solving Access Challenges in Today’s Market
New drug launches face more marketplace scrutiny today than a decade ago. Brand success requires not only communicating the clinical value to providers and patients, but also demonstrating the cost-effectiveness to payers in a real-world setting.
Read the Article
|
|
| COVID-19 |
 |
|
Ripple Effects for Pharma |
Speculating the downstream impact on industry practices is just that right now—speculation. What is sure is some things will never be the same, and some things could even get better, writes Pharm Exec Editor-in-Chief Lisa Henderson
… /Read more/ |
| |
|
| MARKETING |
 |
|
|
| Audio |
 |
|
The Pharm Exec Podcast: Fabulous Pharma Females |
Barbara Ryan, founder of Barbara Ryan Advisors, a member of PharmExec’s Editorial Advisory Board, and the founder of Fabulous Pharma Females discusses the strong community she’s built providing women the opportunity to connect with each other and reinforce their shared commitment to one another
… /Click here to listen/ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
